Company / SG&A per Share
Veracyte, Inc. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.42
FY2025
5-year range
$1.03 / $1.74
FY2021-FY2025
Trend
-5.6%
vs FY2024
Sector context
#120 of 150
Health Care
What the data says
Veracyte, Inc.'s sg&a per share of $1.42 is lower than 80% of companies in the Health Care sector (FY2025). SG&A per Share has fluctuated over the past 10 years, ranging from $0.68 in FY2017 to $1.74 in FY2021.
Based on SEC 10-K filings.
1.42 in FY2025 with a 5-year CAGR of +14.0%.
Increased from $1.20 to $1.42 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +11.4%
- 5-Year CAGR
- +14.0%
- 10-Year CAGR
- -
Sector benchmark
Top 20% in Health CareTop 20% of 150This company $1.42 Sector average $11878.17
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share decreased 5.6% year-over-year.
- Ranks #120 out of 150 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2021.
- Lowest sg&a per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 6.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.42 | -5.6% |
| FY2024 | $1.51 | +26.0% |
| FY2023 | $1.20 | +16.4% |
| FY2022 | $1.03 | -40.9% |
| FY2021 | $1.74 | +135.3% |
| FY2020 | $0.74 | +4.2% |
| FY2019 | $0.71 | +0.1% |
| FY2018 | $0.71 | +3.8% |
| FY2017 | $0.68 | -20.4% |
| FY2016 | $0.86 | -14.3% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026